Evolving Landscape of Renal Cell Carcinoma Treatment (Professor John Wagstaff)

Professor Wagstaff trained as a Medical Oncologist at the Christie Hospital in Manchester. On

completion of his training he took up a position as a Senior Lecturer at the Free University Hospital

in Amsterdam in 1986. In 1994 he was appointed as the Karl Landsteiner Professor of Medical

Oncology at the Free University. In 1998 he became Professor & Head of Haematology and

Oncology at the University of Maastricht in the Netherlands.

Professor Wagstaff is currently Professor of Medical Oncology within the College of Medicine at Swansea

University. He is also Director of the Wales Cancer Research Network and Deputy Director of the

Wales National Institute for Social Care and Health Research Clinical research Centre (NISCHRCRC).

He is a member of the European Society of Medical Oncology, American Society for Clinical

Oncology, Association of Cancer Physicians UK, UK National Cancer Research institute’s

melanoma and renal cancer clinical study Groups and the European Organisation for Research

and Treatment of Cancer.

Professor Wagstaff has co-authored over 127 papers in International Peer reviewed journals. His

main research interests are renal cancers, melanoma and sarcomas. He is interested in

immunotherapy and the interaction between the immune system and the neo-vasculature within

tumours. His main focus has been in developing clinical trials for patients with the above diseases

and conducting translational research to better understand the effects of new treatments on

patients with cancer.